THE USE OF PHARMACOECONOMICS AS A DECISION MAKING TOOL IN
| dc.contributor.author | NAIDOO, PRENISHA | |
| dc.date.accessioned | 2011-05-31T13:21:46Z | |
| dc.date.available | 2011-05-31T13:21:46Z | |
| dc.date.issued | 2011-05-31 | |
| dc.description | MBA - WBS | en_US |
| dc.description.abstract | The high cost of healthcare is of major concern to healthcare providers throughout the world. Globally there has been an increase in the use of pharmacoeconomic tools to help providers to make healthcare reimbursement decisions .South Africa has also become increasingly sensitive to healthcare spend and the South African government has announced proposals to make pharmacoeconomic evaluations part of the drug registration process in the country. It is unclear to what extent pharmacoeconomic evaluations are currently being used in decision making in healthcare. In this research, decision makers from the payer, healthcare prescriber and pharmaceutical manufacturer sectors were interviewed to evaluate the level of current use of pharmacoeconomic evaluations so as to determine the factors driving and inhibiting the use of pharmacoeconomic evaluation tools. Twentyfive semi-structured interviews were conducted and the data obtained were analysed using content analysis, allowing for an in-depth assessment of responses. The research found that pharmacoeconomic evaluations are used at payer and pharmaceutical manufacturer level but its use is limited at the healthcare provider level. The need for cost containment, harmonisation and globalisation in the pharmaceutical industry is a factor driving the use of pharmacoeconomic evaluations. Although these evaluations are not yet a requirement in South Africa, government regulations and requirements are an emerging factor. The use of such evaluations is, however, limited by a lack of education and skills, perceived bias, lack of credibility and perceived poor quality, and lack of methodology, applicability and relevance of economic evaluations in the decision maker’s context and the poor communication and reporting of data. | en_US |
| dc.identifier.uri | http://hdl.handle.net/10539/9977 | |
| dc.language.iso | en | en_US |
| dc.subject | Healthcare | en_US |
| dc.subject | Economics of healthcare | en_US |
| dc.title | THE USE OF PHARMACOECONOMICS AS A DECISION MAKING TOOL IN | en_US |
| dc.type | Thesis | en_US |